These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1919450

  • 1. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM, Kabadi MU.
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul 12; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
    Riddle MC.
    Horm Metab Res; 1996 Sep 12; 28(9):430-3. PubMed ID: 8911978
    [Abstract] [Full Text] [Related]

  • 10. Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies.
    Czech A, Piatkiewicz P, Tatoń J.
    Arch Immunol Ther Exp (Warsz); 2009 Sep 12; 57(6):467-73. PubMed ID: 19885647
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The psychological aspects of diabetics with the secondary failure of sulfonylurea therapy].
    Ratzmann KP.
    Dtsch Med Wochenschr; 1991 Jan 18; 116(3):87-90. PubMed ID: 1898878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
    Reaven GM, Johnston P, Hollenbeck CB, Skowronski R, Zhang JC, Goldfine ID, Chen YD.
    J Clin Endocrinol Metab; 1992 May 18; 74(5):1020-6. PubMed ID: 1569149
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic management of the secondary failure of sulfonylurea therapy].
    Sauer H.
    Dtsch Med Wochenschr; 1985 Jan 04; 110(1):27-30. PubMed ID: 3880697
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.